当前位置：药药网 / 药品 / 美国NDC未完成药物数据库文件(本栏目更新到2026-3-31)
药品名称： 商品名称： 药品NDC： 上市日期： -格式:2020-5-3
注册申请号： 市场分类： 活性成分： 持证企业：
 美国NDC未完成药物数据库文件21130条(本栏目更新到2026-3-31)
药品名称(分析)
商品名
药品NDC
专利人(分析)
上市日期
活性成分
市场分类
规格(分析)
申请号
quetiapine
DRUG FOR FURTHER PROCESSING
0310-0540
AstraZeneca Pharmaceuticals LP
20220422
QUETIAPINE FUMARATE
DRUG FOR FURTHER PROCESSING
400
0310-0540_84554083-2fef-47cf-8a2f-d8c508d03724
Micronized Glycopyrronium Bromide
BULK INGREDIENT
0310-0561
AstraZeneca Pharmaceuticals LP
20220920
GLYCOPYRROLATE
BULK INGREDIENT
68
0310-0561_32ce4cdc-80ff-400b-a917-623d687bc114
Osimertinib
DRUG FOR FURTHER PROCESSING
0310-1353
AstraZeneca Pharmaceuticals LP
20210601
OSIMERTINIB
DRUG FOR FURTHER PROCESSING
40
0310-1353_04138336-9da4-49f5-ac1e-46f2e90c6445
Osimertinib
DRUG FOR FURTHER PROCESSING
0310-1354
AstraZeneca Pharmaceuticals LP
20210601
OSIMERTINIB
DRUG FOR FURTHER PROCESSING
80
0310-1354_04138336-9da4-49f5-ac1e-46f2e90c6445
Sodium Zirconium Cyclosilicate
BULK INGREDIENT
0310-2111
AstraZeneca Pharmaceuticals LP
20211201
SODIUM ZIRCONIUM CYCLOSILICATE
BULK INGREDIENT
243
0310-2111_9055ef31-30ef-46ee-b673-8a7e6efaa911
benralizumab
BULK INGREDIENT
0310-2830
AstraZeneca Pharmaceuticals LP
20220204
BENRALIZUMAB
BULK INGREDIENT
46.7
0310-2830_99557bb3-3e11-4e1b-a14e-670faae0f013
anifrolumab
BULK INGREDIENT
0310-3000
AstraZeneca Pharmaceuticals LP
20210730
ANIFROLUMAB
BULK INGREDIENT
11.7
0310-3000_9b7925da-383a-4755-83b9-d5a7ebdf207f
palivizumab
BULK INGREDIENT
0310-4113
AstraZeneca Pharmaceuticals LP
20220204
PALIVIZUMAB
BULK INGREDIENT
34.6
0310-4113_b9f19a8b-5209-4835-bcca-207a0f4638c4
SAXAGLIPTIN AND METFORMIN HYDROCHLORIDE
DRUG FOR FURTHER PROCESSING
0310-5125
AstraZeneca Pharmaceuticals LP
20220615
METFORMIN HYDROCHLORIDE; SAXAGLIPTIN HYDROCHLORIDE
DRUG FOR FURTHER PROCESSING
1000; 2.5
0310-5125_94f409f4-3e17-4ac4-9193-39af300332a0
SAXAGLIPTIN AND METFORMIN HYDROCHLORIDE
DRUG FOR FURTHER PROCESSING
0310-5135
AstraZeneca Pharmaceuticals LP
20220615
METFORMIN HYDROCHLORIDE; SAXAGLIPTIN HYDROCHLORIDE
DRUG FOR FURTHER PROCESSING
500; 5
0310-5135_94f409f4-3e17-4ac4-9193-39af300332a0
durvalumab
BULK INGREDIENT
0310-5500
AstraZeneca Pharmaceuticals LP
20220204
DURVALUMAB
BULK INGREDIENT
194.2
0310-5500_f7e237ca-a708-4842-9e6e-d4995d5e52f7
acalabrutinib
DRUG FOR FURTHER PROCESSING
0310-5512
AstraZeneca Pharmaceuticals LP
20220804
ACALABRUTINIB MALEATE ANHYDROUS
DRUG FOR FURTHER PROCESSING
100
0310-5512_7b8304be-6781-4eb7-a549-21a4c23b1efb
Micronized Glycopyrronium Bromide
BULK INGREDIENT
0310-5600
AstraZeneca Pharmaceuticals LP
20221021
GLYCOPYRROLATE
BULK INGREDIENT
68
0310-5600_e0bd8286-be3a-437f-90de-35fa19e6b25a
dapagliflozin and metformin hydrochloride
DRUG FOR FURTHER PROCESSING
0310-6325
AstraZeneca Pharmaceuticals LP
20220519
DAPAGLIFLOZIN PROPANEDIOL; METFORMIN HYDROCHLORIDE
DRUG FOR FURTHER PROCESSING
2.5; 1000
0310-6325_0373f30b-69f1-4e05-94c6-d576e0e57606
dapagliflozin and metformin hydrochloride
DRUG FOR FURTHER PROCESSING
0310-6350
AstraZeneca Pharmaceuticals LP
20220519
DAPAGLIFLOZIN PROPANEDIOL; METFORMIN HYDROCHLORIDE
DRUG FOR FURTHER PROCESSING
5; 500
0310-6350_0373f30b-69f1-4e05-94c6-d576e0e57606
dapagliflozin and metformin hydrochloride
DRUG FOR FURTHER PROCESSING
0310-6360
AstraZeneca Pharmaceuticals LP
20220519
DAPAGLIFLOZIN PROPANEDIOL; METFORMIN HYDROCHLORIDE
DRUG FOR FURTHER PROCESSING
5; 1000
0310-6360_0373f30b-69f1-4e05-94c6-d576e0e57606
dapagliflozin and metformin hydrochloride
DRUG FOR FURTHER PROCESSING
0310-6370
AstraZeneca Pharmaceuticals LP
20220519
DAPAGLIFLOZIN PROPANEDIOL; METFORMIN HYDROCHLORIDE
DRUG FOR FURTHER PROCESSING
10; 500
0310-6370_0373f30b-69f1-4e05-94c6-d576e0e57606
dapagliflozin and metformin hydrochloride
DRUG FOR FURTHER PROCESSING
0310-6380
AstraZeneca Pharmaceuticals LP
20220519
DAPAGLIFLOZIN PROPANEDIOL; METFORMIN HYDROCHLORIDE
DRUG FOR FURTHER PROCESSING
10; 1000
0310-6380_0373f30b-69f1-4e05-94c6-d576e0e57606
SAXAGLIPTIN
DRUG FOR FURTHER PROCESSING
0310-7105
AstraZeneca Pharmaceuticals LP
20220616
SAXAGLIPTIN HYDROCHLORIDE
DRUG FOR FURTHER PROCESSING
5
0310-7105_00c56030-be1d-476e-bca3-e510edf5a5e4
DAPAGLIFLOZIN
DRUG FOR FURTHER PROCESSING
0310-8205
AstraZeneca Pharmaceuticals LP
20220519
DAPAGLIFLOZIN PROPANEDIOL
DRUG FOR FURTHER PROCESSING
5
0310-8205_5ae1acf0-62c5-4523-936d-c8d087fc961e
网站地图 - 网站开发 - 网站简介 - 会员服务 - 法律声明 - 联系我们 - 药品招商频道 - 药品信息排行 - 2018年版国家基本药物目录 - 意见反馈
免责声明：以上所展示的信息由企业自行提供，内容的真实性、准确性和合法性由发布企业负责，医药网对此不承担任何责任。
相关链接：医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究　　客服热线：0575-83552251 / 13754370441  QQ客服：药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证：浙B2-20220931　互联网药品信息服务资格证书编号：(浙)-经营性2023-0215　浙公网安备:330683240604819103159
　医药代理商群１：药药网药品采购交流医药代理商群２：药药网药品采购交流2医药代理商群３：药药网药品采购交流3